STAT2

Last updated
STAT2
Available structures
PDB Ortholog search: PDBe RCSB
Identifiers
Aliases STAT2 , ISGF-3, P113, STAT113, IMD44, signal transducer and activator of transcription 2, PTORCH3
External IDs OMIM: 600556 MGI: 103039 HomoloGene: 3952 GeneCards: STAT2
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_019963

RefSeq (protein)

NP_005410
NP_938146

n/a

Location (UCSC) Chr 12: 56.34 – 56.36 Mb Chr 10: 128.11 – 128.13 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Signal transducer and activator of transcription 2 is a protein that in humans is encoded by the STAT2 gene. [5] [6] It is a member of the STAT protein family. This protein is critical to the biological response of type I interferons (IFNs). [7] It functions as a transcription factor downstream of type I interferons. STAT2 sequence identity between mouse and human is only 68%. [8]

Contents

Function

The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. In response to IFN, this protein forms a complex with STAT1 and IFN regulatory factor family protein p48 (IRF9) and form ISGF-3 (IFN-stimulated gene factor-3), in which this protein acts as a transactivator, but lacks the ability to bind DNA directly. [9] The protein mediates innate antiviral activity. Mutations in this gene result in Immunodeficiency 44. [10] ISGF-3 proceeds the activation of genes via the IFN-stimulated response element (ISRE). ISRE-driven genes include Ly-6C, the double-stranded RNA kinase (PKR), 2´ to 5´ oligoadenylate synthase (OAS), MX and potentially MHC class I. [11] Transcription adaptor P300/CBP (EP300/CREBBP) has been shown to interact specifically with this protein, which is thought to be involved in the process of blocking IFN-alpha response by adenovirus. [6]

STAT2 knockout mice are unresponsive to type I IFN and extremely vulnerable to viral infection. They indicate the loss of the type I IFN autocrine loop and several defects in macrophages and T cell responses. Stat2-/- cells show differences in the biological response to IFN-α. [7]

Interactions

STAT2 has been shown to interact with:

STAT2 deficiency

Knockout mice

In double knockout STAT2 mice, an increased proliferation of M1, M2, and M1/M2 coexpressing macrophages during influenza-bacterial super-infection is observed. The bacterial clearance was also impaired by neutralization of IFN-γ (M1) and Arginase-1 (M2) what suggests that pulmonary macrophages expressing a mixed M1/M2 phenotype promote bacterial control during influenza-bacterial super-infection. Therefore the STAT2 signaling is associated with suppressing macrophage activation and bacterial control during influenza-bacterial super-infection. [24] These mice demonstrate no developmental defects. The knockout STAT2 and double knockout STAT mice in Vesicular stromatitis Indiana virus (VSV) model produce at least 10 times more virus plaque-forming units than the wild type (WT). [25] IFN-α pretreatment supplied protection in WT and STAT2+/- cells but not in double knockout STAT2 cells. IFN-γ pretreatment did not provide any antiviral response during infection of VSV. [26] This finding could be explained by the reduced level of STAT1 in cells of STAT2 knockout mice. [7] Additionally, the double knockout STAT2 mice are more sensitive to mouse cytomegalovirus (MCMV), severe fever thrombocytopenia syndrome virus, influenza virus, dengue virus (DNV) and Zika virus than control mice, which suggests that STAT2 plays a critical role in the suppression of virus replication in mice. [27] [28] [29] [30]

Human autosomal recessive (AR) STAT2 deficiency

AR STAT2 deficiency was first time observed in 2 siblings. After routine immunization with measles-mump-rubella, one sibling developed disseminated vaccine-strain measles (MMR) but recovered and second sibling died in infancy from a viral infection due to primary immunodeficiency disorder. Later, the results showed that siblings were homozygous for absent expression of gene for STAT2. Patients with AR STAT2 deficiency have mutations which bring substitutions at important splice sites what leads to defected splicing and premature stop codons leading to a loss of expression of an interferon-stimulated gene. The typical clinical phenotype is disseminated infection after immunization with the live attenuated MMR vaccine. Some patients had also an onset of severe disease in infancy like infection with RSV, norovirus, coxsackievirus, adenovirus or enterovirus. One of the patients had CNS disease after the primary infection with EBV. EBV suppression was delayed in peripheral blood and cerebrospinal fluid as type I interferon signalling plays important role in the initial immune response against EBV. [31] During next 3 years, PCR test showed persistent EBV presence in blood as well as in cerebrospinal fluid despite anti-EBV IgG. CMV and VZV infections were severe as well in few patients. The virus infection was treated by high-dose of intravenous immunoglobulin (IVIG) after which patients recovered and became afebrile within 24 hours. IVIG has anti-inflammatory effect and suggests that the passive immunization could help to control the ongoing viral infections. Therefore, the monthly IgG therapy could be beneficial for patients with STAT2 deficiency during childhood, until their adaptive immune system has sufficiently developed. From the age 5 years, the frequency and severity of viral infections decreased and the age of 10 years the patients were mostly off all medication. In general, the patients with STAT2 deficiency are relatively healthy with no specific defects in their adaptive immunity or developmental abnormalities. These findings show that type I IFN signaling trough ISGF3 is not essential for host defense against the majority of common childhood viral pathogens. Despite a profoundly defective innate IFN response and evident susceptibility to some viral infections, STAT2-deficient individuals can live a relatively healthy life. [32]

It was also reported a homozygous STAT2 missense mutation (R148W/Q) which results to a STAT2 gain of function underlying fatal early-onset autoinflammation in three patients. This mutation leads to a persistent type I IFN response due to defective binding of the mutated STAT2 to ubiquitin specific peptidase 1 (USP18) which is an essential in the negative autofeedback loop where USP18 sterically hinders the binding of JAK1 to IFNAR1. [33] [34] Therefore complete AR STAT2 deficiency usually causes disseminated LAV infection and recurrent natural viral infections. Penetrance is not complete for several viral infections and for complicated live measles vaccine disease. [35] These observation suggest that the phenotype of AR STAT2 deficiency could range from asymptomatic (the healthy adult) to fatal (childhood death from a crushing viral disease). The phenotype is less severe than human complete AR STAT1 deficiency but more severe than IFNAR1 or IFNAR2 deficiency. The human phenotype is less severe than in mice.

Related Research Articles

<span class="mw-page-title-main">Interferon</span> Signaling proteins released by host cells in response to the presence of pathogens

Interferons are a group of signaling proteins made and released by host cells in response to the presence of several viruses. In a typical scenario, a virus-infected cell will release interferons causing nearby cells to heighten their anti-viral defenses.

The JAK-STAT signaling pathway is a chain of interactions between proteins in a cell, and is involved in processes such as immunity, cell division, cell death, and tumour formation. The pathway communicates information from chemical signals outside of a cell to the cell nucleus, resulting in the activation of genes through the process of transcription. There are three key parts of JAK-STAT signalling: Janus kinases (JAKs), signal transducer and activator of transcription proteins (STATs), and receptors. Disrupted JAK-STAT signalling may lead to a variety of diseases, such as skin conditions, cancers, and disorders affecting the immune system.

<span class="mw-page-title-main">Interferon gamma</span> InterPro Family

Interferon gamma (IFN-γ) is a dimerized soluble cytokine that is the only member of the type II class of interferons. The existence of this interferon, which early in its history was known as immune interferon, was described by E. F. Wheelock as a product of human leukocytes stimulated with phytohemagglutinin, and by others as a product of antigen-stimulated lymphocytes. It was also shown to be produced in human lymphocytes. or tuberculin-sensitized mouse peritoneal lymphocytes challenged with Mantoux test (PPD); the resulting supernatants were shown to inhibit growth of vesicular stomatitis virus. Those reports also contained the basic observation underlying the now widely employed IFN-γ release assay used to test for tuberculosis. In humans, the IFN-γ protein is encoded by the IFNG gene.

Interferon tau is a Type I interferon made of a single chain of amino acids. IFN-τ was first discovered in ruminants as the signal for the maternal recognition of pregnancy and originally named ovine trophoblast protein-1 (oTP-1). It has many physiological functions in the mammalian uterus, and also has anti-inflammatory effect that aids in the protection of the semi-allogeneic conceptus trophectoderm from the maternal immune system.

<span class="mw-page-title-main">Protein kinase R</span> Human protein and coding gene

Protein kinase RNA-activated also known as protein kinase R (PKR), interferon-induced, double-stranded RNA-activated protein kinase, or eukaryotic translation initiation factor 2-alpha kinase 2 (EIF2AK2) is an enzyme that in humans is encoded by the EIF2AK2 gene on chromosome 2. PKR is a serine/tyrosine kinase that is 551 amino acids long.

<span class="mw-page-title-main">STAT1</span> Transcription factor and coding gene in humans

Signal transducer and activator of transcription 1 (STAT1) is a transcription factor which in humans is encoded by the STAT1 gene. It is a member of the STAT protein family.

<span class="mw-page-title-main">Tyrosine kinase 2</span> Enzyme and coding gene in humans

Non-receptor tyrosine-protein kinase TYK2 is an enzyme that in humans is encoded by the TYK2 gene.

<span class="mw-page-title-main">STAT6</span> Protein and coding gene in humans

Signal transducer and activator of transcription 6 (STAT6) is a transcription factor that belongs to the Signal Transducer and Activator of Transcription (STAT) family of proteins. The proteins of STAT family transmit signals from a receptor complex to the nucleus and activate gene expression. Similarly as other STAT family proteins, STAT6 is also activated by growth factors and cytokines. STAT6 is mainly activated by cytokines interleukin-4 and interleukin-13.

<span class="mw-page-title-main">STAT4</span> Protein-coding gene in the species Homo sapiens

Signal transducer and activator of transcription 4 (STAT4) is a transcription factor belonging to the STAT protein family, composed of STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B, STAT6. STAT proteins are key activators of gene transcription which bind to DNA in response to cytokine gradient. STAT proteins are a common part of Janus kinase (JAK)- signalling pathways, activated by cytokines.STAT4 is required for the development of Th1 cells from naive CD4+ T cells and IFN-γ production in response to IL-12. There are two known STAT4 transcripts, STAT4α and STAT4β, differing in the levels of interferon-gamma production downstream.

<span class="mw-page-title-main">ISG15</span> Protein-coding gene in the species Homo sapiens

Interferon-stimulated gene 15 (ISG15) is a 17 kDA secreted protein that in humans is encoded by the ISG15 gene. ISG15 is induced by type I interferon (IFN) and serves many functions, acting both as an extracellular cytokine and an intracellular protein modifier. The precise functions are diverse and vary among species but include potentiation of Interferon gamma (IFN-II) production in lymphocytes, ubiquitin-like conjugation to newly-synthesized proteins and negative regulation of the IFN-I response.

<span class="mw-page-title-main">IFNAR2</span> Protein-coding gene in the species Homo sapiens

Interferon-alpha/beta receptor beta chain is a protein that in humans is encoded by the IFNAR2 gene.

<span class="mw-page-title-main">IRF7</span> Protein-coding gene in the species Homo sapiens

Interferon regulatory factor 7, also known as IRF7, is a member of the interferon regulatory factor family of transcription factors.

<span class="mw-page-title-main">Interferon alpha-1</span> Protein-coding gene in the species Homo sapiens

Interferon alpha-1 is a protein that in humans is encoded by the IFNA1 gene.

<span class="mw-page-title-main">IFNA2</span> Mammalian protein found in Homo sapiens

Interferon alpha-2 is a protein that in humans is encoded by the IFNA2 gene.

<span class="mw-page-title-main">IKBKE</span> Protein-coding gene in the species Homo sapiens

Inhibitor of nuclear factor kappa-B kinase subunit epsilon also known as I-kappa-B kinase epsilon or IKK-epsilon is an enzyme that in humans is encoded by the IKBKE gene.

<span class="mw-page-title-main">IRF9</span> Protein-coding gene in the species Homo sapiens

Interferon regulatory factor 9 is a protein that in humans is encoded by the IRF9 gene, previously known as ISGF3G.

<span class="mw-page-title-main">IRF5</span> Protein-coding gene in the species Homo sapiens

Interferon regulatory factor 5 is a protein that in humans is encoded by the IRF5 gene. The IRF family is a group of transcription factors that are involved in signaling for virus responses in mammals along with regulation of certain cellular functions.

<span class="mw-page-title-main">IRF8</span> Protein-coding gene in the species Homo sapiens

Interferon regulatory factor 8 (IRF8) also known as interferon consensus sequence-binding protein (ICSBP), is a protein that in humans is encoded by the IRF8 gene. IRF8 is a transcription factor that plays critical roles in the regulation of lineage commitment and in myeloid cell maturation including the decision for a common myeloid progenitor (CMP) to differentiate into a monocyte precursor cell.

<span class="mw-page-title-main">USP18</span> Protein-coding gene in the species Homo sapiens

Ubiquitin specific peptidase 18 (USP18), also known as UBP43, is a type I interferon receptor repressor and an isopeptidase. In humans, it is encoded by the USP18 gene. USP18 is induced by the immune response to type I and III interferons, and serves as a negative regulator of type I interferon, but not type III interferon. Loss of USP18 results in increased responsiveness to type I interferons and life-threatening autoinflammatory disease in humans due to the negative regulatory function of USP18 in interferon signal transduction. Independent of this activity, USP18 is also a member of the deubiquitinating protease family of enzymes. It is known to remove ISG15 conjugates from a broad range of protein substrates, a process known as deISGylation.

<span class="mw-page-title-main">IFNAR1</span> Protein-coding gene in the species Homo sapiens

Interferon-alpha/beta receptor alpha chain is a protein that in humans is encoded by the IFNAR1 gene.

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000170581 - Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000040033 - Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. Yan R, Qureshi S, Zhong Z, Wen Z, Darnell JE (February 1995). "The genomic structure of the STAT genes: multiple exons in coincident sites in Stat1 and Stat2". Nucleic Acids Research. 23 (3): 459–63. doi:10.1093/nar/23.3.459. PMC   306697 . PMID   7885841.
  6. 1 2 "Entrez Gene: STAT2 signal transducer and activator of transcription 2, 113kDa".
  7. 1 2 3 Park C, Li S, Cha E, Schindler C (December 2000). "Immune response in Stat2 knockout mice". Immunity. 13 (6): 795–804. doi: 10.1016/S1074-7613(00)00077-7 . PMID   11163195.
  8. Park C, Lecomte MJ, Schindler C (November 1999). "Murine Stat2 is uncharacteristically divergent". Nucleic Acids Research. 27 (21): 4191–9. doi:10.1093/nar/27.21.4191. PMC   148693 . PMID   10518610.
  9. Schindler C, Strehlow I (1999). Cytokines and STAT Signaling. Advances in Pharmacology. Vol. 47. pp. 113–74. doi:10.1016/s1054-3589(08)60111-8. ISBN   9780120329489. PMID   10582086.
  10. https://www.genecards.org/cgi-bin/carddisp.pl?gene=STAT2&keywords=STAT2.{{cite web}}: Missing or empty |title= (help)
  11. Lee CK, Gimeno R, Levy DE (November 1999). "Differential regulation of constitutive major histocompatibility complex class I expression in T and B lymphocytes". The Journal of Experimental Medicine. 190 (10): 1451–64. doi:10.1084/jem.190.10.1451. PMC   2195695 . PMID   10562320.
  12. Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A, Livingston DM (September 1996). "Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha". Nature. 383 (6598): 344–7. Bibcode:1996Natur.383..344B. doi:10.1038/383344a0. PMID   8848048. S2CID   4306588.
  13. 1 2 Li X, Leung S, Kerr IM, Stark GR (April 1997). "Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling". Molecular and Cellular Biology. 17 (4): 2048–56. doi:10.1128/mcb.17.4.2048. PMC   232052 . PMID   9121453.
  14. Uddin S, Chamdin A, Platanias LC (October 1995). "Interaction of the transcriptional activator Stat-2 with the type I interferon receptor". The Journal of Biological Chemistry. 270 (42): 24627–30. doi: 10.1074/jbc.270.42.24627 . PMID   7559568.
  15. Yan H, Krishnan K, Greenlund AC, Gupta S, Lim JT, Schreiber RD, et al. (March 1996). "Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein". The EMBO Journal. 15 (5): 1064–74. doi:10.1002/j.1460-2075.1996.tb00444.x. PMC   450004 . PMID   8605876.
  16. Nguyen VP, Saleh AZ, Arch AE, Yan H, Piazza F, Kim J, Krolewski JJ (March 2002). "Stat2 binding to the interferon-alpha receptor 2 subunit is not required for interferon-alpha signaling". The Journal of Biological Chemistry. 277 (12): 9713–21. doi: 10.1074/jbc.M111161200 . PMID   11786546.
  17. Horvath CM, Stark GR, Kerr IM, Darnell JE (December 1996). "Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex". Molecular and Cellular Biology. 16 (12): 6957–64. doi:10.1128/mcb.16.12.6957. PMC   231699 . PMID   8943351.
  18. Martinez-Moczygemba M, Gutch MJ, French DL, Reich NC (August 1997). "Distinct STAT structure promotes interaction of STAT2 with the p48 subunit of the interferon-alpha-stimulated transcription factor ISGF3". The Journal of Biological Chemistry. 272 (32): 20070–6. doi: 10.1074/jbc.272.32.20070 . PMID   9242679.
  19. Lau JF, Nusinzon I, Burakov D, Freedman LP, Horvath CM (January 2003). "Role of metazoan mediator proteins in interferon-responsive transcription". Molecular and Cellular Biology. 23 (2): 620–8. doi:10.1128/mcb.23.2.620-628.2003. PMC   151539 . PMID   12509459.
  20. Huang M, Qian F, Hu Y, Ang C, Li Z, Wen Z (October 2002). "Chromatin-remodelling factor BRG1 selectively activates a subset of interferon-alpha-inducible genes". Nature Cell Biology. 4 (10): 774–81. doi:10.1038/ncb855. PMID   12244326. S2CID   251794.
  21. Li X, Leung S, Qureshi S, Darnell JE, Stark GR (March 1996). "Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha". The Journal of Biological Chemistry. 271 (10): 5790–4. doi: 10.1074/jbc.271.10.5790 . PMID   8621447.
  22. Dumler I, Kopmann A, Wagner K, Mayboroda OA, Jerke U, Dietz R, et al. (August 1999). "Urokinase induces activation and formation of Stat4 and Stat1-Stat2 complexes in human vascular smooth muscle cells". The Journal of Biological Chemistry. 274 (34): 24059–65. doi: 10.1074/jbc.274.34.24059 . PMID   10446176.
  23. Fagerlund R, Mélen K, Kinnunen L, Julkunen I (August 2002). "Arginine/lysine-rich nuclear localization signals mediate interactions between dimeric STATs and importin alpha 5". The Journal of Biological Chemistry. 277 (33): 30072–8. doi: 10.1074/jbc.M202943200 . PMID   12048190.
  24. Gopal R, Lee B, McHugh KJ, Rich HE, Ramanan K, Mandalapu S, et al. (2018-09-25). "STAT2 Signaling Regulates Macrophage Phenotype During Influenza and Bacterial Super-Infection". Frontiers in Immunology. 9: 2151. doi: 10.3389/fimmu.2018.02151 . PMC   6178135 . PMID   30337919.
  25. Farrar JD, Smith JD, Murphy TL, Leung S, Stark GR, Murphy KM (July 2000). "Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2". Nature Immunology. 1 (1): 65–9. doi:10.1038/76932. PMID   10881177. S2CID   38817062.
  26. Takaoka A, Mitani Y, Suemori H, Sato M, Yokochi T, Noguchi S, et al. (June 2000). "Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains". Science. 288 (5475): 2357–60. Bibcode:2000Sci...288.2357T. doi:10.1126/science.288.5475.2357. PMID   10875919.
  27. Jewell NA, Cline T, Mertz SE, Smirnov SV, Flaño E, Schindler C, et al. (November 2010). "Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo". Journal of Virology. 84 (21): 11515–22. doi:10.1128/JVI.01703-09. PMC   2953143 . PMID   20739515.
  28. Ashour J, Morrison J, Laurent-Rolle M, Belicha-Villanueva A, Plumlee CR, Bernal-Rubio D, et al. (November 2010). "Mouse STAT2 restricts early dengue virus replication". Cell Host & Microbe. 8 (5): 410–21. doi:10.1016/j.chom.2010.10.007. PMC   3310429 . PMID   21075352.
  29. Tripathi S, Balasubramaniam VR, Brown JA, Mena I, Grant A, Bardina SV, et al. (March 2017). "A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses". PLOS Pathogens. 13 (3): e1006258. doi: 10.1371/journal.ppat.1006258 . PMC   5373643 . PMID   28278235.
  30. Yoshikawa R, Sakabe S, Urata S, Yasuda J (May 2019). "Species-Specific Pathogenicity of Severe Fever with Thrombocytopenia Syndrome Virus Is Determined by Anti-STAT2 Activity of NSs". Journal of Virology. 93 (10). doi:10.1128/JVI.02226-18. PMC   6498056 . PMID   30814285.
  31. Münz C (2014). "Dendritic cells during Epstein Barr virus infection". Frontiers in Microbiology. 5: 308. doi: 10.3389/fmicb.2014.00308 . PMC   4064564 . PMID   24999343.
  32. Hambleton S, Goodbourn S, Young DF, Dickinson P, Mohamad SM, Valappil M, et al. (February 2013). "STAT2 deficiency and susceptibility to viral illness in humans". Proceedings of the National Academy of Sciences of the United States of America. 110 (8): 3053–8. Bibcode:2013PNAS..110.3053H. doi: 10.1073/pnas.1220098110 . PMC   3581986 . PMID   23391734.
  33. Gruber C, Martin-Fernandez M, Ailal F, Qiu X, Taft J, Altman J, et al. (May 2020). "Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy". The Journal of Experimental Medicine. 217 (5). doi:10.1084/jem.20192319. PMC   7201920 . PMID   32092142.
  34. Duncan CJ, Thompson BJ, Chen R, Rice GI, Gothe F, Young DF, et al. (December 2019). "Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2". Science Immunology. 4 (42): eaav7501. doi:10.1126/sciimmunol.aav7501. hdl: 20.500.11820/3908eba0-5d5c-404d-b79f-08e6bd93b61d . PMC   7115903 . PMID   31836668.
  35. Moens L, Van Eyck L, Jochmans D, Mitera T, Frans G, Bossuyt X, et al. (June 2017). "A novel kindred with inherited STAT2 deficiency and severe viral illness" (PDF). The Journal of Allergy and Clinical Immunology. 139 (6): 1995–1997.e9. doi: 10.1016/j.jaci.2016.10.033 . PMID   28087227.

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.